title: The importance of assessing the dose actually administered in pharmacokinetic trials.
authors.affiliation: Division of Clinical Pharmacology and Toxicology, Beaumont 633, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland. thierry.buclin@chuv.hospvd.ch
authors.forename: Thierry
authors.initials: T
authors.lastname: Buclin
authors.forename: Nancy
authors.initials: N
authors.lastname: Perrottet
authors.forename: Jerome
authors.initials: J
authors.lastname: Biollaz
mesh_terms: D019540:Area Under Curve; D002986:Clinical Trials as Topic / Q000592:standards*; D004305:Dose-Response Relationship, Drug; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D015507:Drugs, Investigational